Literature DB >> 1908046

Design of beam-modulating devices for charged-particle therapy.

P L Petti1, J T Lyman, T R Renner, J R Castro, J M Collier, I K Daftari, B A Ludewigt.   

Abstract

The computer modeling program used to design beam-modulating devices for charged-particle therapy at Lawrence Berkeley Laboratory has been improved to allow a more realistic description of the beam. The original program used a single calculated Bragg peak to design the spread Bragg peak. The range of this curve was shifted so that Bragg curves of varying ranges could be superimposed. The new version of the program allows several measured Bragg curves with different ranges to be used as input, and interpolates between them to obtain the required data for the superposition calculation. The experimental configuration for measuring these input curves simulated therapy conditions. Seven beam-modulating propellers with spread Bragg-peak widths ranging from 2.2 to 14.4 cm were designed and constructed for a 215-MeV/u helium beam using this new design program. Depth-dose distributions produced by these new propellers were in good agreement with predicted distributions, and these propellers are currently being used clinically.

Mesh:

Substances:

Year:  1991        PMID: 1908046     DOI: 10.1118/1.596655

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  4 in total

Review 1.  Clinical gain from improved beam delivery systems.

Authors:  J R Castro; P L Petti; I K Daftari; J M Collier; T Renner; B Ludewigt; W Chu; S Pitluck; T Fleming; J Alonso
Journal:  Radiat Environ Biophys       Date:  1992       Impact factor: 1.925

Review 2.  Results of heavy ion radiotherapy.

Authors:  J R Castro
Journal:  Radiat Environ Biophys       Date:  1995-03       Impact factor: 1.925

Review 3.  The 20th Gray lecture 2019: health and heavy ions.

Authors:  Eleanor A Blakely
Journal:  Br J Radiol       Date:  2020-10-06       Impact factor: 3.039

Review 4.  Research Progress of Heavy Ion Radiotherapy for Non-Small-Cell Lung Cancer.

Authors:  Siqi Liang; Guangming Zhou; Wentao Hu
Journal:  Int J Mol Sci       Date:  2022-02-19       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.